query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_2630_ESMFold_hypothetical_protein	5xda-assembly1.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	5xda-assembly1.cif.gz_B Structural basis for Ufm1 recognition by UfSP	0.058	192	108	148	339	423	538	1.917E-01	51
LOKIASV2_2630_ESMFold_hypothetical_protein	5xda-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	5xda-assembly1.cif.gz_A Structural basis for Ufm1 recognition by UfSP	0.074	199	116	143	341	412	537	2.262E-01	49
LOKIASV2_2630_ESMFold_hypothetical_protein	5ejj-assembly2.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	5ejj-assembly2.cif.gz_B Crystal structure of UfSP from C.elegans	0.075	196	111	145	340	396	516	2.140E-01	45
LOKIASV2_2630_ESMFold_hypothetical_protein	6dec-assembly1.cif.gz_D	LOKIASV2_2630_ESMFold_hypothetical_protein	6dec-assembly1.cif.gz_D Crystal structure of Bos taurus Arp2/3 complex binding with C-terminus of Homo sapiens SPIN90	0.211	71	47	321	381	205	275	5.849E+00	26
LOKIASV2_2630_ESMFold_hypothetical_protein	1df0-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	1df0-assembly1.cif.gz_A Crystal structure of M-Calpain	0.070	204	109	140	343	182	299	3.977E+00	25
LOKIASV2_2630_ESMFold_hypothetical_protein	7l7j-assembly1.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	7l7j-assembly1.cif.gz_B Cryo-EM structure of Hsp90:p23 closed-state complex	0.160	49	40	305	353	142	190	1.838E+00	22
LOKIASV2_2630_ESMFold_hypothetical_protein	1t17-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	1t17-assembly1.cif.gz_A Solution Structure of the 18 kDa Protein CC1736 from Caulobacter crescentus: The Northeast Structural Genomics Consortium Target CcR19	0.073	68	61	301	367	74	141	6.181E+00	20
LOKIASV2_2630_ESMFold_hypothetical_protein	4b9q-assembly4.cif.gz_D	LOKIASV2_2630_ESMFold_hypothetical_protein	4b9q-assembly4.cif.gz_D Open conformation of ATP-bound Hsp70 homolog DnaK	0.107	56	48	306	361	463	517	6.531E+00	20
LOKIASV2_2630_ESMFold_hypothetical_protein	6pny-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	6pny-assembly1.cif.gz_A X-ray Structure of Flpp3	0.100	58	50	305	361	58	115	5.239E+00	18
LOKIASV2_2630_ESMFold_hypothetical_protein	4jne-assembly1.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	4jne-assembly1.cif.gz_B Allosteric opening of the polypeptide-binding site when an Hsp70 binds ATP	0.125	56	47	306	361	469	523	8.604E+00	18
LOKIASV2_2630_ESMFold_hypothetical_protein	7zub-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	7zub-assembly1.cif.gz_A Cryo-EM structure of the indirubin-bound Hsp90-XAP2-AHR complex	0.095	42	36	305	346	143	183	6.181E+00	18
LOKIASV2_2630_ESMFold_hypothetical_protein	7mnz-assembly6.cif.gz_L	LOKIASV2_2630_ESMFold_hypothetical_protein	7mnz-assembly6.cif.gz_L Crystal Structure of Nup358/RanBP2 Ran-binding domain 4 in complex with Ran-GPPNHP	0.098	51	36	306	356	97	137	4.440E+00	17
LOKIASV2_2630_ESMFold_hypothetical_protein	4fcr-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	4fcr-assembly1.cif.gz_A Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization	0.160	49	40	305	353	142	190	5.239E+00	17
LOKIASV2_2630_ESMFold_hypothetical_protein	5zsq-assembly1.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	5zsq-assembly1.cif.gz_B NifS from Hydrogenimonas thermophila, soaked with L-cysteine for 4 min	0.086	46	40	315	359	333	378	9.607E+00	17
LOKIASV2_2630_ESMFold_hypothetical_protein	2akp-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	2akp-assembly1.cif.gz_A Hsp90 Delta24-N210 mutant	0.086	56	49	305	359	118	173	7.706E+00	16
LOKIASV2_2630_ESMFold_hypothetical_protein	5j80-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	5j80-assembly1.cif.gz_A Crystal Structure of Apo Hsp90-alpha N-domain L107A mutant	0.148	53	44	305	357	142	194	7.293E+00	16
LOKIASV2_2630_ESMFold_hypothetical_protein	8eoa-assembly1.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	8eoa-assembly1.cif.gz_B Cryo-EM structure of human HSP90B-AIPL1 complex	0.100	49	43	305	353	143	191	7.293E+00	16
LOKIASV2_2630_ESMFold_hypothetical_protein	8eoa-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	8eoa-assembly1.cif.gz_A Cryo-EM structure of human HSP90B-AIPL1 complex	0.100	49	43	305	353	143	191	6.901E+00	16
LOKIASV2_2630_ESMFold_hypothetical_protein	5oci-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	5oci-assembly1.cif.gz_A Human Heat Shock Protein 90 bound to 6-Hydroxy-3-(3-methyl-benzyl)-1H-indazole-5-carboxylic acid methyl-(4-morpholin-4-yl-phenyl)-amide	0.129	53	42	305	353	138	190	6.531E+00	15
LOKIASV2_2630_ESMFold_hypothetical_protein	4awp-assembly1.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	4awp-assembly1.cif.gz_B Complex of HSP90 ATPase domain with tropane derived inhibitors	0.137	57	45	305	357	139	195	6.531E+00	15
LOKIASV2_2630_ESMFold_hypothetical_protein	8agl-assembly2.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	8agl-assembly2.cif.gz_B Structure of human Heat shock protein 90-alpha N-terminal domain (Hsp90-NTD) variant K112R in complex with JMC31	0.142	55	46	305	359	143	197	7.293E+00	15
LOKIASV2_2630_ESMFold_hypothetical_protein	5lr1-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	5lr1-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HSP90 IN COMPLEX WITH A003498614A.	0.129	53	42	305	353	143	195	7.293E+00	15
LOKIASV2_2630_ESMFold_hypothetical_protein	6n8y-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	6n8y-assembly1.cif.gz_A Hsp90-beta bound to PU-11-trans	0.092	53	44	305	353	143	195	7.706E+00	15
LOKIASV2_2630_ESMFold_hypothetical_protein	3rlp-assembly3.cif.gz_B-2	LOKIASV2_2630_ESMFold_hypothetical_protein	3rlp-assembly3.cif.gz_B-2 Co-crystal structure of the HSP90 ATP binding domain in complex with 4-(2,4-dichloro-5-methoxyphenyl)-6-methylpyrimidin-2-amine	0.137	57	45	305	357	146	202	7.706E+00	15
LOKIASV2_2630_ESMFold_hypothetical_protein	8eob-assembly1.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	8eob-assembly1.cif.gz_B Cryo-EM structure of human HSP90B in the closed state	0.081	48	43	306	353	144	191	7.706E+00	15
LOKIASV2_2630_ESMFold_hypothetical_protein	8eob-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	8eob-assembly1.cif.gz_A Cryo-EM structure of human HSP90B in the closed state	0.081	48	43	306	353	144	191	8.604E+00	15
LOKIASV2_2630_ESMFold_hypothetical_protein	7krj-assembly1.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	7krj-assembly1.cif.gz_B The GR-Maturation Complex: Glucocorticoid Receptor in complex with Hsp90 and co-chaperone p23	0.113	52	42	305	352	144	195	6.901E+00	15
LOKIASV2_2630_ESMFold_hypothetical_protein	5yee-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	5yee-assembly1.cif.gz_A Crystal structure of LokiProfilin1/Rabbit Actin Complex	0.050	58	43	301	358	88	133	9.092E+00	14
LOKIASV2_2630_ESMFold_hypothetical_protein	6eya-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	6eya-assembly1.cif.gz_A Estimation of relative drug-target residence times by random acceleration molecular dynamics simulation	0.129	53	42	305	353	138	190	8.604E+00	14
LOKIASV2_2630_ESMFold_hypothetical_protein	5h22-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	5h22-assembly1.cif.gz_A Hsp90 alpha N-terminal domain in complex with an inhibitor	0.129	53	42	305	353	143	195	8.604E+00	14
LOKIASV2_2630_ESMFold_hypothetical_protein	3k98-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	3k98-assembly1.cif.gz_A HSP90 N-terminal domain in complex with (1R)-2-(5-chloro-2,4-dihydroxybenzoyl)-N-ethylisoindoline-1-carboxamide	0.137	57	45	305	357	146	202	8.143E+00	14
LOKIASV2_2630_ESMFold_hypothetical_protein	4qdc-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	4qdc-assembly1.cif.gz_A Crystal structure of 3-ketosteroid-9-alpha-hydroxylase 5 (KshA5) from R. rhodochrous in complex with FE2/S2 (INORGANIC) CLUSTER	0.078	58	47	306	363	247	298	6.901E+00	14
LOKIASV2_2630_ESMFold_hypothetical_protein	5w12-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	5w12-assembly1.cif.gz_A ADC-7 in complex with boronic acid transition state inhibitor EC04	0.096	52	33	306	357	315	352	6.901E+00	13
LOKIASV2_2630_ESMFold_hypothetical_protein	4kqv-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	4kqv-assembly1.cif.gz_A Topoisomerase iv atp binding domain of francisella tularensis in complex with a small molecule inhibitor	0.076	52	40	305	348	118	169	9.607E+00	13
LOKIASV2_2630_ESMFold_hypothetical_protein	4hxz-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	4hxz-assembly1.cif.gz_A Pyrrolopyrimidine inhibitors of dna gyrase b and topoisomerase iv, part i: structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity.	0.076	52	40	305	348	117	168	9.607E+00	13
LOKIASV2_2630_ESMFold_hypothetical_protein	7yjm-assembly1.cif.gz_B	LOKIASV2_2630_ESMFold_hypothetical_protein	7yjm-assembly1.cif.gz_B Cryo-EM structure of the monomeric atSPT-ORM1 complex	0.104	67	46	306	357	397	463	8.604E+00	13
LOKIASV2_2630_ESMFold_hypothetical_protein	5l07-assembly1.cif.gz_A	LOKIASV2_2630_ESMFold_hypothetical_protein	5l07-assembly1.cif.gz_A Crystal Structure of Quorum-Sensing Transcriptional Activator from Yersinia enterocolitica	0.121	180	130	194	373	13	161	7.293E+00	12
LOKIASV2_2630_ESMFold_hypothetical_protein	4v5z-assembly1.cif.gz_Bb	LOKIASV2_2630_ESMFold_hypothetical_protein	4v5z-assembly1.cif.gz_Bb Structure of a mammalian 80S ribosome obtained by docking homology models of the RNA and proteins into an 8.7 A cryo-EM map	0.096	146	102	209	354	82	195	7.293E+00	12
LOKIASV2_2630_ESMFold_hypothetical_protein	7yjk-assembly1.cif.gz_F	LOKIASV2_2630_ESMFold_hypothetical_protein	7yjk-assembly1.cif.gz_F Cryo-EM structure of the dimeric atSPT-ORM1 complex	0.119	67	45	306	357	396	462	9.607E+00	12
LOKIASV2_2630_ESMFold_hypothetical_protein	6h4j-assembly1.cif.gz_A-3	LOKIASV2_2630_ESMFold_hypothetical_protein	6h4j-assembly1.cif.gz_A-3 Usp25 catalytic domain	0.122	218	138	149	366	330	487	8.143E+00	9
